Anti-Human IFNA1 Recombinant Antibody(Rontalizumab)
-
产品编号
YR1221
-
别名
科研级 Rontalizumab ( 隆利组单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Rontalizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Rontalizumab ( 隆利组单抗 ), Anti-IFNA1 Recombinant Antibody, Research Grade Rontalizumab |
Catalog Number | YR1221 |
Molecular Name | Rontalizumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Rontalizumab is a humanized monoclonal antibody being developed by Genentech. As of November 2009, it is being investigated in a clinical trial for the treatment of systemic lupus erythematosus. |
CAS Number | 948570-30-7 |
Application | ELISA, FCM, IP, FuncS, IF, Neut |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | IFNA1[Homo sapiens] |